Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Epizyme Inc (NASDAQ:EPZM)

15.60
Delayed Data
As of May 26
 -0.55 / -3.41%
Today’s Change
7.02
Today|||52-Week Range
18.50
+28.93%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Ho Tai Ching
Chief Development Officer
Sale5/25/201715,000$16.11$241.7K-3.41%
Ho Tai Ching
Chief Development Officer
Buy5/25/201715,000$8.98$134.7K-3.41%
Copeland Robert A
Buy6/01/201631,538$3.54$111.6K+32.04%
Copeland Robert A
Sale5/02/20175,000$17.44$87.2K-11.11%
Mott David M
Director
Gift7/01/20166,000$10.33$62.0K+51.02%
Copeland Robert A
Sale8/01/20164,000$10.37$41.5K+50.72%
Copeland Robert A
Sale4/04/20172,500$16.36$40.9K-2.50%
Copeland Robert A
Sale4/04/20172,500$16.36$40.9K-2.50%
Copeland Robert A
Sale7/05/20164,000$10.03$40.1K+55.84%
Singer Andrew E
Chief Financial Officer & Executive Vice President
Sale3/31/20172,013$17.09$34.4K-9.04%
Page of 6